- Home
- NTIP vs MODD Comparison
NTIP vs MODD Comparison
Compare NTIP & MODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NTIP | MODD |
|---|---|---|
| Founded | 1990 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Multi-Sector Companies | Industrial Specialties |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 33.3M | 33.3M |
| IPO Year | 2013 | 2019 |
Fundamental Metrics
Financial Performance| Metric | NTIP | MODD |
|---|---|---|
| Price | $1.46 | $4.81 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 34.3K | ★ 307.9K |
| Earning Date | 05-08-2026 | 02-17-2026 |
| Dividend Yield | ★ 6.85% | N/A |
| EPS Growth | 15.38 | ★ 34.62 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $150,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 50.00 | N/A |
| 52 Week Low | $1.16 | $0.12 |
| 52 Week High | $1.66 | $6.16 |
Technical Indicators
Market Signals| Indicator | NTIP | MODD |
|---|---|---|
| Relative Strength Index (RSI) | 51.31 | 62.50 |
| Support Level | $1.34 | $0.43 |
| Resistance Level | $1.47 | $6.04 |
| Average True Range (ATR) | 0.11 | 0.55 |
| MACD | 0.00 | -0.15 |
| Stochastic Oscillator | 39.58 | 26.67 |
Price Performance
Historical ComparisonAbout NTIP Network-1 Technologies Inc.
Network-1 Technologies Inc is involved in the business of the development, licensing, and protection of intellectual property assets. The company's current plan includes continuing to pursue licensing opportunities for its intellectual property assets.
About MODD Modular Medical Inc.
Modular Medical Inc is a development stage medical device company which focuses on the design, development, and commercialization of insulin pumps using modernized technology to increase pump adoption in the diabetes marketplace. The company's products seek to serve both the type 1 and the rapidly growing, especially in terms of device adoption, type 2 diabetes markets.